The author is the Wu Yuzhang distinguished professor at the School of Finance and a research fellow at Changjiang River ...

We spoke with Scott Jones, PhD, SVP & CSO at BioBridge Global (BBG) to understand the challenges of product-specific potency ...

(Bloomberg/Natalie Lung) — The Uber Technologies Inc. veteran overseeing its safety operations is set to depart, setting off a second round of executive changes this year at a time when the rideshare ...

In British folklore, the cuckoo’s song is the symphony that accompanies spring, but when the summer solstice arrives, the bird falls silent. As the days descend into winter, the cuckoo returns to the ...

The authors of the study, published in Cell Reports Medicine, are optimistic that it could pave the way for potential ...

From football fields to military training grounds, head injuries are leaving lasting marks on the brain in ways we're only ...

Scientists have carried out research in mice that suggests it could be possible to reverse the disease although trials with ...

It's been a long time coming: Four years after Omeros came up short in its bid to gain an FDA approval for stem cell transplant drug narsoplimab, the Seattle biotech has finally scored its ...

Omeros has won U.S. Food and Drug Administration approval of its Yartemlea treatment for an often-fatal complication of stem-cell transplants. Omeros on Wednesday said the approval covers Yartemlea ...

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

Hippocratic AI has expanded its focus with the acquisition of Grove AI, a specialist in AI used in pharma R&D, to complement ...